Compliance with osteoporosis therapy is the weakest link

被引:61
作者
Compston, Juliet E. [1 ]
Seeman, Ego
机构
[1] Univ Cambridge, Addenbrookes Hosp, Sch Clin, Dept Med, Cambridge CB2 2QQ, England
[2] Austin & Repatriat Med Ctr, Dept Endocrinol, Heidelberg, Vic 3084, Australia
关键词
D O I
10.1016/S0140-6736(06)69394-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:973 / 974
页数:2
相关论文
共 12 条
  • [1] CANNER PL, 1980, NEW ENGL J MED, V303, P1038
  • [2] The impact of compliance with osteoporosis therapy on fracture rates in actual practice
    Caro, JJ
    Ishak, KJ
    Huybrechts, KF
    Raggio, G
    Naujoks, C
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 (12) : 1003 - 1008
  • [3] The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: A randomized controlled
    Clowes, JA
    Peel, NFA
    Eastell, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) : 1117 - 1123
  • [4] Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study
    Cooper, A.
    Drake, J.
    Brankin, E.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (08) : 896 - 905
  • [5] Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis
    Cramer, JA
    Amonkar, MM
    Hebborn, A
    Altman, R
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (09) : 1453 - 1460
  • [6] Epidemiology and outcomes of osteoporotic fractures
    Cummings, SR
    Melton, LJ
    [J]. LANCET, 2002, 359 (9319) : 1761 - 1767
  • [7] GUILERA M, 2005, OSTEOPOROSIS INT, V17, P1
  • [8] TREATMENT ADHERENCE AND RISK OF DEATH AFTER A MYOCARDIAL-INFARCTION
    HORWITZ, RI
    VISCOLI, CM
    BERKMAN, L
    DONALDSON, RM
    HORWITZ, SM
    MURRAY, CJ
    RANSOHOFF, DF
    SINDELAR, J
    [J]. LANCET, 1990, 336 (8714) : 542 - 545
  • [9] Assessment of compliance with osteoporosis treatment and its consequences in a managed care population
    Huybrechts, KF
    Ishak, KJ
    Caro, JJ
    [J]. BONE, 2006, 38 (06) : 922 - 928
  • [10] Compliance with drug therapies for the treatment and prevention of osteoporosis
    McCombs, JS
    Thiebaud, P
    McLaughlin-Miley, C
    Shi, JH
    [J]. MATURITAS, 2004, 48 (03) : 271 - 287